These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 14506129)
1. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Chimienti F; Hogg RC; Plantard L; Lehmann C; Brakch N; Fischer J; Huber M; Bertrand D; Hohl D Hum Mol Genet; 2003 Nov; 12(22):3017-24. PubMed ID: 14506129 [TBL] [Abstract][Full Text] [Related]
2. ARS Component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda. Mastrangeli R; Donini S; Kelton CA; He C; Bressan A; Milazzo F; Ciolli V; Borrelli F; Martelli F; Biffoni M; Serlupi-Crescenzi O; Serani S; Micangeli E; El Tayar N; Vaccaro R; Renda T; Lisciani R; Rossi M; Papoian R Eur J Dermatol; 2003; 13(6):560-70. PubMed ID: 14721776 [TBL] [Abstract][Full Text] [Related]
4. Mal de Meleda (MDM) caused by mutations in the gene for SLURP-1 in patients from Germany, Turkey, Palestine, and the United Arab Emirates. Eckl KM; Stevens HP; Lestringant GG; Westenberger-Treumann M; Traupe H; Hinz B; Frossard PM; Stadler R; Leigh IM; Nürnberg P; Reis A; Hennies HC Hum Genet; 2003 Jan; 112(1):50-6. PubMed ID: 12483299 [TBL] [Abstract][Full Text] [Related]
5. A novel mutation in the ARS (component B) gene encoding SLURP-1 in a Turkish family with mal de Meleda. Muslumanoglu MH; Saracoglu N; Cilingir O; Basmaci T; Urer S; Sabuncu I; Demir S; Bademci G; Artan S Br J Dermatol; 2006 Aug; 155(2):467-9. PubMed ID: 16882192 [No Abstract] [Full Text] [Related]
6. Biochemical Basis of Skin Disease Mal de Meleda: SLURP-1 Mutants Differently Affect Keratinocyte Proliferation and Apoptosis. Shulepko MA; Bychkov ML; Shenkarev ZO; Kulbatskii DS; Makhonin AM; Paramonov AS; Chugunov AO; Kirpichnikov MP; Lyukmanova EN J Invest Dermatol; 2021 Sep; 141(9):2229-2237. PubMed ID: 33741389 [TBL] [Abstract][Full Text] [Related]
7. Mutations in the gene encoding SLURP-1 in Mal de Meleda. Fischer J; Bouadjar B; Heilig R; Huber M; Lefèvre C; Jobard F; Macari F; Bakija-Konsuo A; Ait-Belkacem F; Weissenbach J; Lathrop M; Hohl D; Prud'homme JF Hum Mol Genet; 2001 Apr; 10(8):875-80. PubMed ID: 11285253 [TBL] [Abstract][Full Text] [Related]
8. Mal de Meleda without mutations in the ARS coding sequence. van Steensel MA; van Geel MV; Steijlen PM Eur J Dermatol; 2002; 12(2):129-32. PubMed ID: 11872406 [TBL] [Abstract][Full Text] [Related]
9. Identification of recurrent mutations in the ARS (component B) gene encoding SLURP-1 in two families with mal de Meleda. Ward KM; Yerebakan O; Yilmaz E; Celebi JT J Invest Dermatol; 2003 Jan; 120(1):96-8. PubMed ID: 12535203 [TBL] [Abstract][Full Text] [Related]
10. Human Secreted Ly-6/uPAR Related Protein-1 (SLURP-1) Is a Selective Allosteric Antagonist of α7 Nicotinic Acetylcholine Receptor. Lyukmanova EN; Shulepko MA; Kudryavtsev D; Bychkov ML; Kulbatskii DS; Kasheverov IE; Astapova MV; Feofanov AV; Thomsen MS; Mikkelsen JD; Shenkarev ZO; Tsetlin VI; Dolgikh DA; Kirpichnikov MP PLoS One; 2016; 11(2):e0149733. PubMed ID: 26905431 [TBL] [Abstract][Full Text] [Related]
11. A recurrent mutation in the ARS (component B) gene encoding SLURP-1 in Turkish families with mal de Meleda: evidence of a founder effect. Hu G; Yildirim M; Baysal V; Yerebakan O; Yilmaz E; Inaloz HS; Martinez-Mir A; Christiano AM; Celebi JT J Invest Dermatol; 2003 Jun; 120(6):967-9. PubMed ID: 12787122 [TBL] [Abstract][Full Text] [Related]
12. Primary sensory neuronal expression of SLURP-1, an endogenous nicotinic acetylcholine receptor ligand. Moriwaki Y; Watanabe Y; Shinagawa T; Kai M; Miyazawa M; Okuda T; Kawashima K; Yabashi A; Waguri S; Misawa H Neurosci Res; 2009 Aug; 64(4):403-12. PubMed ID: 19409425 [TBL] [Abstract][Full Text] [Related]
14. Pseudodominant inheritance with the G86R mutation in the ARS gene in Mal de Meleda. Chao SC; Huang CY; Lai FJ; Yang MH Int J Dermatol; 2006 Dec; 45(12):1456-8. PubMed ID: 17184264 [No Abstract] [Full Text] [Related]
15. Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily. Adermann K; Wattler F; Wattler S; Heine G; Meyer M; Forssmann WG; Nehls M Protein Sci; 1999 Apr; 8(4):810-9. PubMed ID: 10211827 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in the properties of mutant secreted lymphocyte antigen 6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda. Adeyo O; Oberer M; Ploug M; Fong LG; Young SG; Beigneux AP Br J Dermatol; 2015 Oct; 173(4):1066-9. PubMed ID: 25919322 [No Abstract] [Full Text] [Related]
17. SLURP1 mutation-impaired T-cell activation in a family with mal de Meleda. Tjiu JW; Lin PJ; Wu WH; Cheng YP; Chiu HC; Thong HY; Chiang BL; Yang WS; Jee SH Br J Dermatol; 2011 Jan; 164(1):47-53. PubMed ID: 20854438 [TBL] [Abstract][Full Text] [Related]
18. Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands. Moriwaki Y; Yoshikawa K; Fukuda H; Fujii YX; Misawa H; Kawashima K Life Sci; 2007 May; 80(24-25):2365-8. PubMed ID: 17286989 [TBL] [Abstract][Full Text] [Related]
19. A novel mutation in the ARS (component B) gene encoding SLURP-1 in a family with Mal de Meleda. Yerebakan O; Hu G; Yilmaz E; Celebi JT Clin Exp Dermatol; 2003 Sep; 28(5):542-4. PubMed ID: 12950349 [TBL] [Abstract][Full Text] [Related]
20. Gene Symbol: ars. Disease: Mal de Meleda. Abdelhak S; Charfeddine C; Mokni M; Mousli RB; Elkares R; Bouchlaka C; Boubaker S; Ghedamsi S; Baccouche D; Osman AB; Dellagi K Hum Genet; 2004 May; 114(6):609. PubMed ID: 15176391 [No Abstract] [Full Text] [Related] [Next] [New Search]